| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |